Maryland State Retirement & Pension System’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
Other funds holding LGND
Maryland State Retirement & Pension System's LGND Position: Q2 2026 in Review
Maryland State Retirement & Pension System increased its Ligand Pharmaceuticals (LGND) stake by 1.8% in Q2 2026, buying an estimated $12K and bringing the position to 2,923 shares worth $924K. The position accounts for 0.02% of the portfolio, ranked #606.
Maryland State Retirement & Pension System first reported a position in LGND in Q3 2021 and has held it in 19 quarters since. The position peaked at $1.03M in Q4 2021. 417 funds tracked by Wall St. Rank hold LGND as of Q2 2026.
- Maryland State Retirement & Pension System held 2,923 shares of Ligand Pharmaceuticals worth $924K as of Q2 2026.
- Maryland State Retirement & Pension System bought 51 Ligand Pharmaceuticals shares in Q2 2026, an estimated $12K.
- Ligand Pharmaceuticals made up 0.02% of Maryland State Retirement & Pension System's portfolio in Q2 2026, its #606 holding.
- Maryland State Retirement & Pension System first reported a position in Ligand Pharmaceuticals in Q3 2021 and has held it in 19 quarters since.
- Maryland State Retirement & Pension System's Ligand Pharmaceuticals position peaked at $1.03M in Q4 2021.
- 417 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q2 2026.
Based on Maryland State Retirement & Pension System's 13F filing for Q2 2026, filed 30 Jul 2026.